Use of sentinel lambs to survey the effect of an education programme on control of transmission of Echinococcus granulosus in South Powys, Wales.
In this article the effects of an education programme (area II) on transmission of Echinococcus granulosus from dogs to sheep in Wales and of substitution of the education programme by a 6-weekly anthelmintic control programme (area I) are compared with the situation in an area where no control interventions had occurred (area III). The education programme failed to prevent transmission of E. granulosus to sentinel lambs examined at 15 months of age, 6%, 4%, and 10% of which were infected in areas I, II, and III, respectively. Educational efforts did, however, show some positive effects; for example, significantly more farmers (87-98%) in areas I, II, and III used praziquantel to treat their dogs compared with 39% of farmers in a lowland area in the east of England where E. granulosus is absent. In particular, the interval between treatments of dogs was significantly shorter in areas targeted with education programmes, and 38% of farmers in area I treated dogs at a 4-6 week interval, as did 17% in area II and 10% in area III, compared with only 3% in the lowland area. Also, more dogs in Wales (65-88%) were treated at an interval of < or = 3 months, whereas most of the dogs in the lowland area (64%) were treated at intervals of > or = 6 months. The shorter treatment intervals with praziquantel may account for the significantly fewer positive coproantigen tests among dogs in area I (6.3%) and area II (5.6%) compared with area III (23.9%).
Lloyd
S
S
Department of Clinical Veterinary Medicine, University of Cambridge, England.
Walters
T M
TM
Craig
P S
PS
D000293:Adolescent; D000818:Animals; D000923:Anticestodal Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs; D004443:Echinococcosis / Q000635:transmission / Q000662:veterinary*; D004446:Echinococcus; D006266:Health Education; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011223:Praziquantel / Q000627:therapeutic use; D012756:Sheep; D012757:Sheep Diseases / Q000517:prevention & control*; D014852:Wales
D000923:Anticestodal Agents; D011223:Praziquantel